Early Engagement With an AI-Enabled Digital Health Tool Predicts Weight Loss, Real-World Study Presented at ObesityWeek 2026 Finds
By six months, the share of participants with a BMI over 40 fell from 31.3% to 22.5%, while the share with a BMI under
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
Welldoc®, an AI-powered health technology leader, today announced new real-world data showing that early engagement with an AI-enabled digital health tool predicted weight loss among adults with overweight or obesity. Holly F. Lofton, MD, DiplABOM, of NYU Grossman School of Medicine, a Welldoc scientific advisor, presented the findings on Sunday, Nov. 15 at 2:30 p.m. ET in the poster hall at ObesityWeek® 2026. (Poster number 538).
Dr. Lofton co-authored the study with Mansur Shomali, MD, CM, FACE, Chief Medical Officer at Welldoc, and colleagues.
“In my practice, I see that the first few months of a weight management program are when nutrition and other habits take shape, and this study suggests that’s when digital engagement matters most,” said Dr. Lofton. “What stood out to me was that people had similar results at six months even as they used the app less. That’s encouraging for anyone focused on helping patients build habits that last.”
The study evaluated adults with overweight or obesity who used the tool on their mobile devices as part of a dietitian-led weight management program at a single health system. Participants used it to track weight, activity and nutrition and to receive AI-powered coaching. Researchers analyzed de-identified data from participants who reached three months (n=720) and six months (n=355) in the program. Participants were predominantly women (82%), nearly two-thirds were aged 40 to 64, and the mean baseline BMI was 37.7 kg/m². Researchers used Spearman’s rank correlation and ordinary least squares regression to identify predictors of weight loss.
Key findings include:
- Meaningful weight loss. Average weight loss was 3.8% (9.3 pounds) at three months and 7.1% (17.0 pounds) at six months.
- A favorable shift in BMI. By six months, the share of participants with a BMI over 40 fell from 31.3% to 22.5%, while the share with a BMI under 27 nearly doubled, from 7.6% to 14.6%.
- Early engagement predicted results. How often participants engaged in their first 90 days was a significant predictor of six-month weight loss (p<0.0001). Among those followed for six months, participants who lost more than 10% of their body weight averaged 9.0 app engagements per day during that early period, compared with 4.9 among those who gained weight.
- Food logging mattered most. Dietary logging was the primary predictor of weight loss. Step counts and physical activity were not.
- Results held as app use tapered. Participants whose engagement fell by more than half after the first 90 days achieved median six-month weight loss similar to those who sustained engagement (6.9% vs. 6.8%), suggesting habits formed early may support weight loss maintenance as app use naturally declines.
The study was observational and conducted within a single health system, so the findings show association rather than causation.
“Obesity care is advancing quickly, but long-term success still depends on the everyday habits people build,” said Dr. Shomali. “These real-world findings suggest that supporting engagement early, especially around nutrition, may help people form habits that carry forward. We’ll continue studying how AI-enabled support can help people reach and sustain their weight management goals.”
About Welldoc
Welldoc® is an AI-powered health technology company integrating personalized, real-time and actionable insights into the daily lives of individuals living with complex conditions, enabling improved health and outcomes. Welldoc’s comprehensive digital health platform provides AI-powered digital coaching across pre-diabetes, diabetes, hypertension, heart failure and weight and obesity management, with integrated mental wellbeing and sleep support. Welldoc has recently expanded their capabilities beyond cardiometabolic health to other complex areas, including brain health, oncology and immunology. Welldoc is an FDA-cleared digital health solution that guides individuals through the complicated journey of living with diabetes by enabling them to self-manage their care while enhancing connections to their healthcare team. The company partners with life sciences companies, health plans, health systems and employers with the goal of extending care, improving health and reducing costs. Welldoc is also an approved participant in the Centers for Medicare & Medicaid Services (CMS) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model as a credentialed Medicare Part B supplier.
Welldoc has achieved 11 510(k) clearances for diabetes functionality within its digital health platform and holds a portfolio of 69 patents for its AI and technology. With over 100 clinical publications, Welldoc has also built an extensive library of clinical research, including many publications focused on the value of combining CGM with AI-powered digital health solutions. Welldoc has been showcased in prestigious conferences and publications, including South by Southwest, the Wall Street Journal and the Economist. The company has been recognized extensively, including TIME’s Top Health Tech Companies for the past two years, the “Best Overall Digital Health Company” by MedTech Breakthrough for the past four years, and the 2025 Healthcare AI Impact Awards, Innovation Awards by Business Intelligence Group. For more information, visit www.welldoc.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261116308850/en/
Media gallery
